Emerging studies suggest this peptide, a dual agonist targeting both GLP-1 and GIP , could represent a significant step forward for weight management . Initial clinical investigations have shown https://madbookmarks.com/story21580245/a-retatrutide-substance-a-breakthrough-in-body-management